Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice of annual general meeting in Frill Holding AB

STOCKHOLM, Wed, 27 May, 2020 12.00 CESTN.B The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail. The shareholders of Frill Holding AB (Publ), reg. no. 559026-8016 (the “Company”) are hereby convened to the annual general meeting to be held on Friday 26 June 2020 at 14.00 in Advokatfirman Nerpin’s premises at Birger Jarlsgatan 2, 3rd floor, in Stockholm.Notification of attendance Shareholders who wish to attend the meeting must be registered in the

Results from clinical trial with Diamyd[®] in children at high risk for type 1 diabetes

Results from the investigator initiated prevention trial DiAPREV-IT 2,  where 26 healthy children at high risk for type 1 diabetes have been treated with two subcutaneous injections of Diamyd[®] or placebo,  showed that over the course of two years, one individual in the Diamyd[®] arm and two individuals in the placebo arm were diagnosed. No safety concerns were raised and the safety profile was comparable between the active arm and the placebo arm.The trial, led by Associate Professor Helena Elding Larsson, Lund University, was originally designed to follow 80 children over the course of

SenzaGen receives GLP approval

SenzaGen, which develops animal-free in vitro safety tests, has received the important GLP approval from Swedac for its laboratory and the use of its test platform GARD™. The internal work began in 2019 and today, May 27, the Company received the GLP approval. This is a substantial regulatory milestone since the GLP status gives SenzaGen access to customers seeking to file their products with regulators such as the Swedish Medical Products Agency or the FDA.GLP stands for Good Laboratory Practice and is a quality system of requirements and principles to assure the quality of non-clinical

Decisions made at the Ponsse Plc Annual General Meeting

Ponsse Plc’s Annual General Meeting was held in Vieremä today on 27 May 2020. Financial statementsAt the AGM, the financial statements of the parent company and the Group were approved and members of the Board of Directors and the President and CEO were discharged from liability for the 2019 financial period. DividendsIt was decided that EUR 0.30 per share be paid in dividends for 2019. The dividend shall be paid to all shareholders who are listed in the shareholder register maintained by Euroclear Finland Ltd as a company shareholder on the record date, 29 May 2020. The dividend

Neles corporate identity reflects its vision and values

Metso Corporation’s press release on May 27, 2020 at 12:30 p.m. EESTNeles, which is to become an independent listed company upon the partial demerger of Metso, is assuming a new corporate brand and visual identity. The new identity will be fully adopted at the completion of the transaction when Neles starts its independent business operations. The completion of the transaction is expected to take place on June 30, 2020. Neles’ corporate logo – a bold Neles wordmark in the company’s signature blue – signifies a customer-focused, ambitious and forward-looking company with reliability as

Photocure ASA - share capital increase registered

Oslo, Norway, 27 May 2020: Reference is made to the stock exchange announcement by Photocure ASA ("Photocure") published 25 May 2020 regarding a share capital increase following the exercise of employee share options.The issuance of 123,750 new shares has been registered with the Norwegian Register of Business Enterprises. Following registration, the share capital of Photocure is NOK 12,049,887.50 divided on 24,099,775 shares, each with a par value of NOK 0.50. For further information, please contact:PhotocureCFO Erik DahlTel: +47 450 55 000E-mail: ed@photocure.no www.

Tikkurila's disposal of treasury shares as part of its matching share plan

Tikkurila Oyj, Stock Exchange Release, May 27, 2020 at 12:00 (EEST) Tikkurila's disposal of treasury shares as part of its matching share plan A total of 3,500 Tikkurila Oyj's treasury shares have been transferred without consideration to three key persons participating in the company's Matching Share Plan (2017-2019), which was originally announced on May 31, 2017. Shares were granted based on the authorization given to the Board of Directors by the Annual General Meeting held on April 11, 2019. Following the transfer, the number of treasury shares now stands at 15,961 shares.

myFC in feasibility study with RahRah Technologies

RahRah Technologies LLC, a Qatar-based start-up of last-mile electric mobility, has initiated a feasibility study together with Swedish micro fuel cell company myFC. The objective is to explore the integration of myFC’s hybrid fuel cell technology into vehicles designed and produced by RahRah Technologies.The cooperation entails a feasibility study to evaluate myFC’s fuel cell technology in powering the vehicles designed and produced by RahRah Technologies, such as e-tuktuks and e-scooters. “I believe our ability to offer freedom-in-design is a great opportunity for the fast-growing e-

BioStock: Iconovo’s ICOcap inhaler receives CE marking

Iconovo’s strong start to 2020 shows no signs of slowing down as we approach summer. The company just added a CE marking to the list of reached milestones, making the company’s capsule-based dry powder inhaler ICOcap authorized for use in clinical trials by European customers. BioStock takes a closer look.Read the full article at biostock.se: https://www.biostock.se/en/iconovos-icocap-inhaler-receives-ce-marking/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se 

OrganoTex® textile impregnation is launched in the UK with FTUK as agent

OrganoClick is since two years supplying fluorocarbon-free and biodegradable textile impregnations and maintenance products for clothes and garments under the brand OrganoTex®. The products are sold in Sweden, Finland and Norway in stores like Naturkompaniet, Partioaitta, Alewalds, Skistar, Team Sportia, among others. OrganoTex® is now launched in the UK with the sport and outdoor agent FTUK as sales partner.[OrganoTex product family]  OrganoTex ® Textile Waterproofing Spray-On and Wash-In has been developed during several years and have been designed to give good water repellancy,

This year's edition of the Baltic Sea Festival has been cancelled

The Baltic Sea Festival, which was to take place in August 2020, has been cancelled.  Even though it had been intended to make the festival a digital project, the planning conditions due to the Covid-19 outbreak have finally made that impossible. "We had prepared to present the festival digitally, even though the circumstances would have been difficult.  Since the outbreak of covid-19 prevented physical audiences in Berwaldhallen, we have anyway continued to present live concerts every week on P2 as well as web-streamed on Berwaldhallen Play;  we were pleased with the positive

XMReality Remote Guidance to be used by Iristick smart glasses

XMReality AB and Iristick NV have entered a partnership to offer XMReality Remote Guidance together with Iristick’s smart glasses. Iristick smart glasses are specifically built for industrial applications and hence meet safety glasses standards. XMReality Remote Guidance can now be integrated with the glasses to solve complex problems faster and more efficient and will be part of Iristick’s offer.This collaboration allows field service engineers and operators to use XMReality Remote Guidance together with Iristick.Z1 smart glasses to get remote assistance. Smart glasses provide a handsfree

Neste MY Renewable Diesel available at more than 200 sales points in Sweden by year-end

Neste Corporation, Press Release, 27 May 2020 at 10 a.m. (EET)  Neste, the world’s largest producer of renewable diesel and the 3rd most sustainable company in the world*, deepens its partnership with one of Sweden’s largest fuel companies, OKQ8. Neste MY Renewable Diesel ™, produced from renewable and sustainable raw materials, will become available at 130 OKQ8 network stations by the end of 2020, also for private customers. The total Neste MY Renewable Diesel sales points in Sweden will more

NENT Group appoints new CEO for refocused Studios operations

· Alexander Bastin appointed as SVP and CEO of NENT Studios from 1 September · Morten Mogensen appointed as SVP and Head of NENT Studios businesses that are currently being sold · Extended Group Executive Management team will now comprise five SVPs Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, today announced changes to the leadership of its NENT Studios businesses. Alexander Bastin has been appointed as SVP and CEO of NENT Studios from 1 September, while Morten Mogensen has been appointed from the same date as SVP and Head of the NENT

Demonstrating strong customer focus and therapeutic expertise, TFS CRO has been awarded new Covid-19 studies.

TFS is working in collaboration with sponsors, at an unprecedented pace. Our operational teams are participating in various studies, targeting coronavirus disease patients or analyzing the real world evidence to bring treatments to COVID-19 patients faster. TFS is continuously recognized for agility as well as the knowledge and experience of our teams. In-depth expertise in the field of internal medicine as well as strong presence in Spain allow TFS to partner with customers on four more trials on Covid-19. The studies total up to more than 3300 patients in 17 sites covering full a

Nordea Economic Outlook: Long time to heal economic scars

The outlook for the world economy remains bleak. The COVID-19 pandemic has evolved into the biggest health crisis in 100 years, and the draconian measures to curb the spread of infection have had enormous financial costs. While economic growth will soon be on the rise again as locked-down communities gradually reopen, it will likely be a long time before the economic scars have fully healed. The Nordic economies have also been hit hard by the containment measures and global recession. However, thanks to good public finances, they are relatively well equipped to deal with the long-term

Scandion Oncology announces that the first patient has received treatment with SCO-101 in combination with FOLFIRI.

Scandion Oncology A/S (“Scandion Oncology”) is pleased to announce that the first patient has received treatment with SCO-101 and FOLFIRI with no unexpected SCO-101-related events observed. By measuring an exposure biomarker during treatment, it was observed that SCO-101 caused the expected changes in the level of this exposure biomarker, demonstrating that SCO-101 was present in the body in an effective concentration.Due to the COVID-19 pandemic most activities around clinical trials have been on hold or slowed down in Denmark for a couple of months. However, as COVID-19 is now under

Redsense Medical selects Etteplan to further develop and industrialize their medical device

Etteplan press release May 27, 2020 at 9.45 a.m. EEST Redsense Medical trusts Etteplan in further developing and industrializing their hose clamp used in hemodialysis treatment. The project includes industrialization of a prototype previously developed by Etteplan in order to launch the product on the market. Redsense Medical and Etteplan have been cooperating for many years within the medtech area and the development of medical devices. Etteplan has previously supported Redsense in the development of a blood loss detection device. The device is used for monitoring and alarm in the

Notice of the Annual General Meeting in Realfiction Holding AB (publ)

The shareholders of Realfiction Holding AB (publ), reg. no 559110-4616 (”the Company”) are hereby summoned to the Annual General Meeting on Thursday, 25 June 2020.  In light of the coronavirus, the Annual General Meeting is conducted through advance voting pursuant to temporary regulations. Therefore, it will not be possible to attend this year’s Meeting in person or by proxy.RIGHT TO PARTICIPATEThose wishing to participate in the Annual General Meeting must be registered as shareholders in the share register maintained by Euroclear Sweden AB as of Thursday, 18 June 2020. NOTIFICATION

Cantargia publishes interim report for first quarter 2020

Cantargia AB’s (”Cantargia”) interim report for first quarter 2020 is now available on the company’s web page www.cantargia.com/en/investors/financial-reports.Significant events in the first quarter · Cantargia advanced its development of CAN04 by successfully scaling up production. · Cantargia completed a directed share issue which raised SEK 410 million before transaction costs. · Cantargia acquired a patent portfolio from Cellerant Therapeutics Inc. that includes a US patent on IL1RAP as target for antibody therapy in leukemia. Significant events after the end of the period

Alfa Laval signs agreement for waste heat recovery units – newly developed for land-based applications

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has signed an agreement with a Chinese system builder for the delivery of land-based waste heat recovery units. Alfa Laval has supplied large marine waste heat recovery systems for a long time. This newly developed unit – Alfa Laval Micro – is much smaller in size and specifically targets land-based applications. The frame agreement signals the market’s early acceptance of the new solution.The agreement stretches over two years and comprises the delivery of Alfa Laval Micro units to power plants in

The Board of Directors of Recipharm resolves on a rights issue of approximately SEK 2,017 million and announces the terms

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE SECTION “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE.  The Board of Directors of Recipharm AB (publ) (”Recipharm”, the ”Company” or the ”Group”) has, with the support of the authorisation from the Annual General Meeting on 12 May 2020,

There are no items matching the current filter
There are no more items matching the current filter
Back to top